Bleeding Endpoints (Included Surgical Site)
Enoxaparin, N = 1588
Apixaban, N = 1596
% of Patients Experiencing
Bleeding Event
10
8
6
4
2
0
1.39%
n = 22
0.69%
n = 11
4.28%
n = 68
2.88%
n = 46
6.80%
n = 108
5.33%
n = 85
Major Bleeding
Major + CRNM Bleeding
All Bleeding
ELIQUIS increases the risk of bleeding and can cause serious, potentially fatal, bleeding